Skip to main content
SpringerLink
Log in

Abnormal Variation of the Immune System as Related to Cancer

  • Chapter
Influence of the Host on Tumor Development

Part of the book series: Cancer Growth and Progression ((CAGP,volume 4))

Abstract

In his excellent review of ‘Phylogeny and Ontogeny’ Clyde Dawe (62) called a most promising endeavor to investigate the control mechanisms of cell replication and differentiation. Dawe (62) as well as Good and Finstad (103) also hint at a certain relationship between the phylogency of cellular immune mechanisms and oncogeny.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrahamova J, Majsky A, Koutecky J: HLA-antigene bei germinativen Tumoren von verschiedener Lokalisation. Onkologie 4:19, 1981

    Article  PubMed  CAS  Google Scholar 

  2. Ahmed A, Smith AH, Folks T: Murine T-cell heterogeneity. Cancer Treatm Rep 63:613, 1979

    CAS  Google Scholar 

  3. Alexander P: Escape from immune control by the shedding of membrane antigens: influence on metastatic behavior of tumor cells in: Fundamental aspects of neoplasia (A.A. Gottlieb et al., eds) pp. 101–8, Springer Verlag, N.Y., 1975

    Google Scholar 

  4. Alexander P, Eccles SA, Gauci CLL: The significance of macrophages in human and experimental tumors. Ann N.Y.AS. 276:124, 1976

    Article  CAS  Google Scholar 

  5. Allison AC: Tumor development following immunosuppression. Proc Roy Soc Med 63:1077, 1970

    PubMed  CAS  Google Scholar 

  6. Allison AC: Immunological surveillance against tumor cells in: Cancer, Vol. 4 (F.F. Becker ed.) pp. 237–58 Plenum Press, N.Y., 1975

    Google Scholar 

  7. Armstrong MYK, Gleichmann E, Gleichmann H, Beldotti L, Andre-Schwartz J: Chronic allogenic disease. II. Development of lymphomas. J Exp Med 132:417, 1970

    Article  PubMed  CAS  Google Scholar 

  8. Armstrong MYK, Ruddle NH, Lipman MB, Richards FF: Tumor induction by immunologically activated murine leukemia virus. J Exp Med 137:1163, 1973

    Article  PubMed  CAS  Google Scholar 

  9. Arora PK, Miller HC, Aronson LD: Alpha-1-antitrypsin is an effector of immunological stasis. Nature 274:589, 1978

    Article  PubMed  CAS  Google Scholar 

  10. Arseneau JC, Sponzo R, Lewin RW, Schnipper LE, Bonner H, Young RC, Canellos GP, Johnson RE, De Vita VT: Nonlymphomatous malignant tumors complicating Hodg-kin’s disease. Possible association with intensive therapy. N Engl J Med 287:1119, 1972

    Article  PubMed  CAS  Google Scholar 

  11. Askenase PW, Hayden BJ, Gershon RK: Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med 141–697 1975

    Google Scholar 

  12. Astaldi A, Astaldi GCB, Wijermans P, Dagna-Bricarelli F, Kater L, Stoop JW, Vossen JM: Experiences with thymosin in primary immunodeficiency disease. Cancer Treatm Rep 62:1779, 1978

    CAS  Google Scholar 

  13. Atkinson K, Biggs JC, Ting A, Concannon AJ, Dodds AJ, Pun A: Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation. Br J Haematol 53:265, 1982

    Article  Google Scholar 

  14. Bacacs T, Gergely P, Cornain S, Klein E: Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int J Cancer 19:441, 1977

    Article  Google Scholar 

  15. Bach J-F: Les hormones thymiques. Nouv Presse Med 8:2797, 1979

    PubMed  CAS  Google Scholar 

  16. Bach J-F, Carnaud C: Thymic factors. Progr Allergy 21:342, 1976

    Article  CAS  Google Scholar 

  17. Bach J-F, Dardenne M, Davis AJS: Early effect of adult thymectomy. Nature (New Biol) 231:110, 1971

    Article  CAS  Google Scholar 

  18. Baldwin RW: Immunological aspects of chemical carcinogenesis. Adv Cancer Res 18:1, 1973

    Article  PubMed  CAS  Google Scholar 

  19. Baldwin RW: Immune responses to tumor specific and embryonic antigens on chemically-induced tumours. Progr Immunol 3:538, 1977

    Google Scholar 

  20. Ball JK: Immunsuppression and carcinogenesis: contrasting effects with 7, 12. dimethylbenz-α-anthracene, benz-α-pyrene and 3-methylchloranthrene. J Natl Cancer Inst 44:1, 1970

    PubMed  CAS  Google Scholar 

  21. Bar RS, Delor CJ, Clausen KP, Hurtbise P, Henle W, Hewetson JF: Fatal infectious mononucleosis in a family. N Engl J Med 290:363, 1974

    Article  PubMed  CAS  Google Scholar 

  22. Bartholomaeus WN, Bray AE, Papadimitriou JM: Immune response to a transplantable malignant melanoma in mice. J Natl Cancer Inst 53:1065, 1974

    PubMed  CAS  Google Scholar 

  23. Bartlett GL: Effect of host immunity on the antigenic strength of primary tumors. J Natl Cancer Inst 49:493, 1972

    PubMed  CAS  Google Scholar 

  24. Bast RC, Zbar B, Borsos T, Rapp HJ: BCG and Cancer. N Engl J Med 290:1413, 1974

    Article  PubMed  Google Scholar 

  25. Bendinelli M, Nardini L: Immunodepression by Rowson-Parr virus in mice. II. Effect of Rowson/Parr virus infection on the antibody response to sheep red cells in vivo and in vitro. Infect Immunity 7:160, 1973

    CAS  Google Scholar 

  26. Bergholz M, Brehler R, Schauer A, Krueger G, Fischer R, Herbst EW: Die SJL-lymphadenopathie als Tiermodell. Verh Dtsch Ges Path 67: 1983

    Google Scholar 

  27. Bergholz M, Krueger G, Schauer A: Lethal cardiorespiratory failure in a case of progressive angioimmunoblastic lymphadenopathy (AIL). Path Res Pract 173:417, 1982

    PubMed  CAS  Google Scholar 

  28. Bergholz M, Rahlf G, Doehring KM: Familial hemophagocytic reticulosis (Farquhar). Path Res Pract 163:267, 1978

    PubMed  CAS  Google Scholar 

  29. Blaese RM, Strober W, Brown RS, Waldmann TA: The Wiscott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet 1:1056, 1968

    Article  PubMed  CAS  Google Scholar 

  30. Bloom BR: Molecular mechanisms of mononuclear cell function — introduction. Fed Proc 37:2741, 1978

    Google Scholar 

  31. Borzy MS, Hong R, Horowitz SD, Gilbert E, Kaufman D, De Mendonca W, Oxelius V-A, Dictor M, Pachman L: Fatal lymphoma after transplantation of cultured thymus in children with combined immunodeficiency disease. N Engl J Med 301:565, 1979

    Article  PubMed  CAS  Google Scholar 

  32. Boyse EA, Old LJ: Some aspects of normal and abnormal cell surface genetics. Ann Rev Genetics 3:269, 1969

    Article  Google Scholar 

  33. Broder S, Edelson RL, Lutzner MA, Nelson DL, McDermott RP, Durm ME, Goldmann CK, Meade BD, Waldmann TA: The Sézary syndrome. A malignant proliferation of helper T-cells. J Clin Invest 58:1297, 1976

    Article  PubMed  CAS  Google Scholar 

  34. Broder S, Uchiyama T, Waldmann T A, Current Concepts in Immunoregulatory T-cell neoplasms. Cancer Treatm Rep 63:607, 1979

    CAS  Google Scholar 

  35. Bubenik J, Koldovsky P, Svoboda J, Adamova B: Induction of tumours in mice with three variants of Rous sarcoma virus and studies on the immunobiology of these tumours. Folia Biol (Praha) 13:29, 1967

    CAS  Google Scholar 

  36. Burnet MF, The concept of immunological surveillance. Progr Exp Tumor Res 13:1, 1970

    PubMed  CAS  Google Scholar 

  37. Bystryn JC, Smalley JR: Identification and solubilization of iodinated cell surface human melanoma associated antigens. Int J Cancer 20:165, 1977

    Article  PubMed  CAS  Google Scholar 

  38. Camiener GW, Wechter WJ: Immunosuppression — Agents, procedures, speculations and prognosis. Progr Drug Res 16:67, 1972

    CAS  Google Scholar 

  39. Cantor H, Boyse EA: Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med 141:1376, 1975

    Article  PubMed  CAS  Google Scholar 

  40. Cantor H, Boyse EA: Regulation of cellular and humoral immune responses by T cell subclasses. Cold Spring Harbor Symp Quant Biol 41:23, 1977

    PubMed  Google Scholar 

  41. Cerottini JC, Brunner KT: Cell-mediated cytotoxicity allograft rejection and tumor immunity. Adv Immunol 18:67, 1974

    Article  PubMed  CAS  Google Scholar 

  42. Chan SH, Day NE, Khor TH, Kunaratnam N, Chia KB: HLA markers in the development and prognosis of NPC. Chinese cancer campaign 5:205, 1981

    Google Scholar 

  43. Chazan R, Haran-Ghera N: The role of thymus subpopulations in ‘T’leukemia development. Cell Immunol 23:356, 1976

    Article  PubMed  CAS  Google Scholar 

  44. Chiari H: Ueber das feingewebliche Bild der bei Mesantho-inbehandlung zu beobachtenden Lymphknotenschwellung. Wien Klin Wschr 63:11, 1951

    Google Scholar 

  45. Chieco-Bianci L, Sendo F, Aoki T, Barrera OL: Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness? J Natl Cancer Inst 52:1345, 1974

    Google Scholar 

  46. Chism SE, Burton RC, Warner NL: In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. J Natl Cancer Inst 57:377, 1976

    PubMed  CAS  Google Scholar 

  47. Cohen AM: Host immunity to growing sarcomas: tumor-specific serum inhibition of tumor-specific cellular immunity. Cancer 31:81, 1973

    Article  PubMed  CAS  Google Scholar 

  48. Coltman CA, Dixon DO: Second malignancies complicating Hodgkin’s disease: a southwest oncology group 10-year followup. Cancer Chemother Rep 66:1023, 1982

    Google Scholar 

  49. Coombs MM: Chemical carcinogenesis: a view at the end of the first half-century. J Path 130:117, 1980

    Article  PubMed  CAS  Google Scholar 

  50. Cooperband SR, Badger AM, Davis RC, Schmid K, Mannick JA: The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro. J Immunol 109:154, 1972

    PubMed  CAS  Google Scholar 

  51. Cooperbrand SR, Nimberg R, Schmid K, Glasgow AH, Mannick JA: Humoral immunosuppressive factors. Transplant Proc 8:225, 1976

    Google Scholar 

  52. Costanzi JJ, Gagliano RG, Delaney F, Harris N, Thurman GB, Sakai H, Goldstein AL, Loukas D, Cohen GB, Thomson PD: The effect of thymosin on patients with disseminated malignancies. Cancer 40:14, 1977

    Article  PubMed  CAS  Google Scholar 

  53. Cremer NE: Selective immunoglobulin deficiencies in rats infected with Moloney virus. J Immunol 99:71, 1967

    PubMed  CAS  Google Scholar 

  54. Cremer NE: Immunosuppression mediated by Moloney leukemia virus infection. In: Virus tumorigenesis and immunogenesis, Ceglowski S, Friedman H (eds), N.Y., Academic Press, 1973

    Google Scholar 

  55. Cremer NE, Taylor DON, Lenette EH: Quantitation of immunoglobulin- and virus-producing cells in rats infected with Moloney leukemia virus. Immunol 107:689, 1971

    CAS  Google Scholar 

  56. Cunningham-Rundles C, Cunningham-Rundles S, Iwata T, Incefy G, Garofalo JA, Mendendez-Botet C, Lewis V, Twomey JJ, Good RA: Zinc deficiency, depressed thymic hormones, and T lymphocyte dysfunction in patients with hypogammaglobulinemia. Clin Immunol Immunopathol 21:287, 1981

    Article  Google Scholar 

  57. Currie GA: The role of circulating antigen as an inhibitor of tumour immunity in man. Brit J Cancer 28:153, 1973

    Google Scholar 

  58. Currie GA, Alexander P: Spontaneous shedding of TSTA by viable sarcoma cells: Its possible role in facilitating metastatic spread. Brit J Cancer 29:72, 1974

    Article  PubMed  CAS  Google Scholar 

  59. Dacie JV, Galton DAG, Gordon-Smith EC, Harrison CV: Non-tropical ‘idiopathic splenomegaly’: a follow-up study of ten patients described in 1969. Brit Haematol 38:185, 1978

    Article  CAS  Google Scholar 

  60. Daguillard F, Griscelli C: Studies of T- and B-lymphocytes function in immunodeficiency. Biomedicine 30:13, 1979

    PubMed  CAS  Google Scholar 

  61. Davey GC, Currie GA, Alexander P: Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: correlation with metastatic capacity. Brit J Cancer 33:9, 1976

    Article  PubMed  CAS  Google Scholar 

  62. Dawe CJ: Phylogeny and oncogeny. Natl Cancer Inst Monogr 31:1, 1969

    PubMed  CAS  Google Scholar 

  63. De Bruyns PP: The effect of X-rays on the lymphatic nodule, with reference to the dose and relative sensitivities of different species. Anat Rec 101:373, 1948

    Article  Google Scholar 

  64. De Larco JE, Reynolds R, Carlberg K, Engle C, Todaro GJ: Sarcoma growth factor from mouse sarcoma virus transformed cells. Purification by binding and elution from epidermal growth factor receptor-rich cells. J Biol Chem 255:3685, 1980

    PubMed  Google Scholar 

  65. Dent PB, Peterson RD, Goor RA: A defect in cellular immunity during the incubation period of passage A leukemia in C3H mice. Proc Soc Exp Biol Med 119:869, 1965

    PubMed  CAS  Google Scholar 

  66. Dent PB, Louis JA, McCulloch DB, Dunnett CW, Cerottini J-C: Correlation of elevated C1q binding activity and car-cinoembryonic antigen levels with clinical features and prognosis in bronchogenic carcinoma. Cancer 45:130, 1980

    Article  PubMed  CAS  Google Scholar 

  67. Dixon FJ, Talmage W, Maurer PH: Radiosensitive and radioresistant phases in the antibody responses. Immunol 68:693, 1952

    CAS  Google Scholar 

  68. Doell RG, De Vaux St Cyr C, Grabar P: Immune reactivity prior to development of thymic lymphoma in C57BL mice. Int J Cancer 2:103, 1967

    Article  PubMed  CAS  Google Scholar 

  69. Domzig W, Lohmann-Matthes ML: Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell. Europ J Immunol 9:267, 1979

    Article  CAS  Google Scholar 

  70. Dosch H-M, Jason J, Gelfand EW: Transient antibody deficiency and abnormal T-suppressor cells induced by Phenytoin. N Engl J Med 306:406, 1982

    Article  PubMed  CAS  Google Scholar 

  71. Drew IS: Immunological surveillance against neoplasia: an immunological quandary. Human Path 10:5, 1979

    Article  CAS  Google Scholar 

  72. Engers HD, Louis J: Dissociation of the humoral and cell-mediated responses to allogens in mice by sublethal whole-body irradiation. Scand J Immunol 10:509, 1979

    Article  PubMed  CAS  Google Scholar 

  73. Editorial: Immunocompromised homosexuals. Lancet II:1328, 1981

    Google Scholar 

  74. Fahey IL: Cancer in the immunosuppressed patient. Ann Intern Med 75:310, 1971

    PubMed  CAS  Google Scholar 

  75. Farquhar JW, Claireaux AE: Familial haemophagocytic reticulosis. Arch Dis Childh 27:519, 1952

    Article  PubMed  CAS  Google Scholar 

  76. Farr AG, Dorf ME, Unanue ER: Secretion of mediators following T lymphocyte-macrophage interaction is regulated by a major histocompatibility complex. Proc Natl Acad Sci USA 74:3542, 1977

    Article  PubMed  CAS  Google Scholar 

  77. Fenyö EM, Klein E, Klein G, Swiech K: Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. J Natl Cancer Inst 40:69, 1968

    PubMed  Google Scholar 

  78. Fernandez G, Nair M, Onoe K, Tanaka T, Floyd R, Good RA: Impairment of the cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci USA 76:457, 1979

    Article  Google Scholar 

  79. Fidler IJ: In vitro studies of cellular mediated immunostim-ulation of tumor growth. J Natl Cancer Inst 50:1307, 1973

    PubMed  CAS  Google Scholar 

  80. Fogel M, Gorelik E, Segal S, Feldman M: Differences in cell surface antigens of tumor metastases and those of the local tumor. J Natl Cancer Inst 62:585, 1979

    PubMed  CAS  Google Scholar 

  81. Friedman H, ed: Subcellular factors in immunity. Ann NY Acad Sci 332, 1979

    Google Scholar 

  82. Friedman H, Kateley JR, Lymphocyte surface receptors and leukemia virus-induced immunosuppression. Amer J Clin Path 63:735, 1975

    CAS  Google Scholar 

  83. Friedman H, Thompson G, Halper JP, Knowles DM: OT- cell: a human T-cell chronic lymphocytic leukemia that produces IL-2 in high titer. J Immunol 128:935, 1982

    PubMed  CAS  Google Scholar 

  84. Fudenberg HH: Genetically determined immune deficiency as the predisposing cause of ‘autoimmunity’ and the lymphoid neoplasia. Amer J Med 51:295, 1971

    Article  PubMed  CAS  Google Scholar 

  85. Gabrielsen AE, Good RA: Chemical suppression of adaptive immunity. Adv Immunol 6:91, 1967

    Article  PubMed  CAS  Google Scholar 

  86. Gajl-Peczalska K, Chartrand SJ, Bloomfield CD: Abnormal immunoregulation in patients with non-Hodgkin’s malignant lymphomas. I. Increased helper function of peripheral blood T lymphocytes. Clin Immunol Immunopathol 23:366, 1982

    Article  PubMed  CAS  Google Scholar 

  87. Gatti RA, Good RA: The immunological deficiency diseases. Med Clin N Amer 54:281, 1970

    PubMed  CAS  Google Scholar 

  88. Gatti RA, Good RA: Occurrence of malignancy in immunodeficiency diseases. A literary review. Cancer 28:89, 1971

    Article  PubMed  CAS  Google Scholar 

  89. Gershon RK, Birnbaum-Mokyr M, Mitchell MS: Activation of suppressor T cells by tumour cells and specific antibody. Nature 250:594, 1974

    Article  PubMed  CAS  Google Scholar 

  90. Gery I, Waksman BH: Potentiation of the T lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med 136:143, 1972

    Article  PubMed  CAS  Google Scholar 

  91. Gilette RW, Fox A: Changes caused in the homing patterns of chromium 51-labelled lymphoid cells by Moloney sarcoma virus infection. J Natl Cancer Inst 58:1621, 1977

    Google Scholar 

  92. Gleichmann E, Gleichmann H: Graft-versus-host reaction: A pathogenetic principle for the development of drug allergy, autoimmunity, and malignant lymphoma in non-chimeric individuals — hypothesis. Z Krebsforsch 85:91, 1976

    Article  CAS  Google Scholar 

  93. Gleichmann E, Gleichmann H: Spectrum of diseases caused by alloreactive T-cells, mode of sensitization to the drug diphenylhydantoin, and possible role of SLE-typical self-antigens in B-cell triggering. In: Immunoregulation and Autoimmunity, edited by Krakauer RS, Cathcart MK, Elsevier-North Holland, Amsterdam, 1980, pp 73–83

    Google Scholar 

  94. Gleichmann H, Gleichmann E: Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunsurveillance theory. Klin Wschr 51:255, 1973

    Article  PubMed  CAS  Google Scholar 

  95. Glicksman AS, Pajak TF, Gottlieb A, Nissen N, Stutzman L, Cooper MR: Second malignant neoplasms in patients successfully treated for Hodgkin’s disease: A cancer and leukemia group B study. Cancer Chemother Rep 66:1035, 1982

    CAS  Google Scholar 

  96. Goldstein AL, Hooper JA, Schulof RS, Cohen GH: Thymosin and the immunopathology of aging. Fed Proc 33:2053, 1974

    PubMed  CAS  Google Scholar 

  97. Goldstein AL, Thurman GB, Low TLK, Rossio JL, Trivers GE: Hormonal influences on the reticuloendothelial system: current status of the role of thymosin in the regulation and modification of immunity. J Reticuloendothelial Soc 23:253, 1978

    CAS  Google Scholar 

  98. Goldstein AL, Low TLK, Thurman GB, Zatz MM, Hall N, Chen J, Hu SK, Naylor PB, McClure JE: Current status of thymosin and other hormones of the thymic gland. Rec Progr Horm Res 37:369, 1981

    PubMed  CAS  Google Scholar 

  99. Goldstein G: The isolation of thymopoietin (thymin). Ann NY Acad Sci 249:177, 1975

    Article  PubMed  CAS  Google Scholar 

  100. Goldstein G, ed: Molecular control of proliferation and differentiation. Academic Press, NY, 1977

    Google Scholar 

  101. Good RA: Agammaglobulinemia: A provocative experiment of nature. Bull Univ Hosp Minn Med Found 26:1, 1954

    Google Scholar 

  102. Good RA, Finstad J: The association of lymphoid malignancy and immunologic functions. In: Proc Int Conf Leukemia/Lymphoma, edited by Zorafonetis CJD, Lea & Febiger, Philadelphia, 1968, p 175–197

    Google Scholar 

  103. Good RA, Finstad J: Neoplasia and primitive vertebrate phylogeny: echinoderms prevertebrates and fishes — a review. Natl Cancer Inst Monogr 31:41, 1969

    PubMed  CAS  Google Scholar 

  104. Gospodarowicz D, Ill CR, Birdwell CR: Effects of fibroblast and epidermal growth factors on ovarian cell proliferation in vitro. Endocrinology 100:1108, 1977

    Article  PubMed  CAS  Google Scholar 

  105. Green HS, Harvey EK: The induction of lymphomas in hamsters by heterologous tumor transplants. Amer J Path 51:447, 1967

    Google Scholar 

  106. Greenberg AH, Greene M: Non-adaptive rejection of small tumour inocula as a model of immune surveillance. Nature 264:356, 1976

    Article  PubMed  CAS  Google Scholar 

  107. Greene MI, Pierres A, Dorf ME: The I-J subregion codes for determinants on suppressor factor(s) which limit the contact sensitivity response to picryl chloride. J Exp Med 146:293, 1977

    Article  PubMed  CAS  Google Scholar 

  108. Griscelli C, Durandy A, Virelizier JL, Ballet JJ, Daguillard F: Selective defect of precursor T-cells associated with apparently normal B-lymphocytes in severe combined immunodeficiency disease. J Pediat 93:404, 1978

    Article  PubMed  CAS  Google Scholar 

  109. Grünwald HW, Rosner F: Acute leukemia and immunosuppressive drug use. Arch Intern Med 139:461, 1979

    Article  PubMed  Google Scholar 

  110. Grundmann E, ed: Metastatic tumor growth. Cancer Campaign 4:1, 1980

    Google Scholar 

  111. Gryboski J: Gastrointestinal problems in the infant (acrodermatitis enteropathica). In: Major problems in clinical pediatrics, Vol XIII, Saunders, Philadelphia, 1975, p 628–30

    Google Scholar 

  112. Hadden JW, Stewart WE, eds: The lymphokines. Humana Press, Clifton NJ, 1981

    Google Scholar 

  113. Hanto DW, Friczera G, Purtilo DT, Sacramento K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253, 1981

    PubMed  CAS  Google Scholar 

  114. Harada S, Tatsumi E, Lipscomb H, Purtilo DT: Responses to Epstein-Barr Virus in Immune Deficient Patients, pp. 123–141 in: Purtilo DT. Immune Deficiency and Cancer. New York, Plenum Press, 1984.

    Google Scholar 

  115. Heimer R, Klein G: Circulating immune complexes in sera of patients with Burkitt’s lymphoma and nasopharyngeal carcinoma. Int J Cancer 18:310, 1976

    Article  PubMed  CAS  Google Scholar 

  116. Heine UI, Krueger GRF, Karpinski A, Munoz E, Krueger MB: Quantitative light and electron microscopic changes of thymic reticular epithelial cells during Moloney virus induced lymphoma development. J Cancer Res Clin Oncol 106:153, 1983a

    Article  PubMed  Google Scholar 

  117. Heine UI, Krueger GRF, Munoz E, Karpinski A: Altered thymic epithelial cells may be decisive for Moloney virus induced lymphoma development. EMSA Meeting, Phoenix Arizona, book of abstr. 41: 1983b

    Google Scholar 

  118. Hellström I, Hellström KE: Studies on cellular immunity and its serum mediated inhibition in Moloney virus induced mouse sarcomas. Int J Cancer 4:587, 1969

    Article  PubMed  Google Scholar 

  119. Hellström I, Hellström KE: Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms. Cancer 34:1461, 1974

    Article  PubMed  Google Scholar 

  120. Hellström I, Hellström KE, Pierce GE: In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer 3:461, 1968

    Article  Google Scholar 

  121. Hellström KE, Hellström I: Cell mediated immunity to mouse tumors: some recent findings. Ann NY Acad Sci 276:176, 1976

    Article  PubMed  Google Scholar 

  122. Henderson ES, Krueger GRF: Medications and their toxicity. In: Handb allg Path, edited by Altmann HW et al., Springer Verl, Berlin Heidelberg NY, 1977, pp 745–791

    Google Scholar 

  123. Himmelweit F, ed: The collected papers of Paul Ehrlich. Pergamon, London, 1957

    Google Scholar 

  124. Hirsch MS: Immunological activation of oncogenic viruses. In: Virus tumorigenesis and immunogenesis, edited by Ceglowski WS, Friedman H, Academic Press, NY, 1973, p 131–140

    Google Scholar 

  125. Hirsch MS, Black PH, Tracy GS, Leibowitz S, Schwartz RS: Leukemia virus activation in chronic allogeneic disease. Proc Natl Acad Sci USA 67:1914, 1970

    Article  PubMed  CAS  Google Scholar 

  126. Hogg N, Koszinowski K, Mitchinson NA: Principles governing the response to the cell surface antigens. Progr Immunol 3:532, 1977

    Google Scholar 

  127. Hoover RT, Fraumeni JF: Risk of cancer in renal-transplant recipients. Lancet II:55, 1973

    Article  Google Scholar 

  128. Ioachim HL, Dorsett B, Sabbath M: Loss and recovery of phenotypic expression of gross leukemia virus. Nature (New Biol) 237:215, 1972

    Article  CAS  Google Scholar 

  129. Ioachim HL, Keller S, Sabbath M: Antigenic expression as a determining factor of tumor growth in gross virus leukemia. Progr Exp Tumor Res 19:284, 1974

    PubMed  CAS  Google Scholar 

  130. Iwata T, Incefy GS, Cunningham-Rundles S, Cunningham-Rundles C, Smithwick E, Geller N, O’Reilly R, Good RA: Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. Amer J Med 71:385, 1981

    Article  PubMed  CAS  Google Scholar 

  131. Jerry LM, Rowden G, Cano PO, Phillips TM, Deutsch GF, Capek A, Hartman P, Lewis MG: Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol 5:845, 1976

    Article  PubMed  CAS  Google Scholar 

  132. Jones TC: Hereditary diseases. In: Pathology of laboratory animals, Vol II, edited by Benirschke K, Garner FM, Jones TC, Springer Verl NY, 1978, pp 1982–2018

    Google Scholar 

  133. Jose DG, Seshadri R: Circulating immune complexes in human neuroblastoma; direct assay and role in blocking specific cellular immunity. Int J Cancer 13:824, 1974

    Article  PubMed  CAS  Google Scholar 

  134. Kahn MF, Arlet J, Bloch-Michel H, Caroit M, Chanoat Y, Renier JC: Le risque du leucose aigüe après traitément des rheumatismes inflammatoire chroniques et des connectivités par les cytotoxiques a visée immunosuppressive. Rev Rheu-matisme 46:163, 1971

    Google Scholar 

  135. Kail MA, Hellström I: Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens. Immunol 114:1083, 1975

    Google Scholar 

  136. Kaplan AM, Morahan PS: Macrophage mediated tumor cell cytotoxicity. Ann NY Acad Sci 267:134, 1976

    Article  Google Scholar 

  137. Karamaju LS, Levine PH, Sundar SK, Ablashi DV, Faggioni A, Armstrong GR, Bertram G, Krueger GRF: Epstein-Barr virus related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 70:643, 1983

    Google Scholar 

  138. Karpinski A: Dysregulative Lymphomgenese, ein Computer-assistiertes Modell. Thesis, Univ Cologne, 1983

    Google Scholar 

  139. Kater L, Oosterom R, McClure J, Goldstein AL: Presence of thymosin-like factors in human thymic epithelium conditioned medium. Int J Immunopharmacol 1:273, 1979

    Article  PubMed  CAS  Google Scholar 

  140. Kaur P, Schulof RS, Miller DR, Steinherz P, Good RA, Gupta S: Immunoregulation by blasts from null cells and T cell leukemias. Cancer 49:43, 1982

    Article  PubMed  CAS  Google Scholar 

  141. Kenady DE, Chretien PB, Potvin C, Simon RM: Thymosin reconstruction of t-cell deficits in vitro in cancer patients. Cancer 39:575, 1977

    Article  PubMed  CAS  Google Scholar 

  142. Keski-Oja, Heine UI, Rapp UR, Wetzel B: Epidermal growth factor-induced alterations in proliferating mouse epithelial cells. Exp Cell Res 128:279, 1980

    Article  PubMed  CAS  Google Scholar 

  143. Kiessling R, Petranyi G, Klein G, Wigzell H: Non-T-cell resistance against a mouse Moloney lymphoma. Int J Cancer 17:275, 1976

    Article  PubMed  CAS  Google Scholar 

  144. Kim H, Nathwani BM, Rappaport H: So-called ‘Lennert’s lymphoma’: Is it a clinicopathologic entity? Cancer 45:1379, 1980

    Article  PubMed  CAS  Google Scholar 

  145. Kim U, Baumler A, Carruther M: Immunological escape mechanisms in spontaneous metastasizing mammary tumors. Proc Natl Acad Sci USA 72:1012, 1975

    Article  PubMed  CAS  Google Scholar 

  146. Kiuchi M, Takasugi M: The nonselective cytotoxic cells. J Natl Cancer Inst 56:575, 1976

    PubMed  CAS  Google Scholar 

  147. Klein E, Klein G: Antibody response and leukemia development in mice inoculated neonatally with the Moloney virus. Cancer Res 25:851, 1965

    PubMed  CAS  Google Scholar 

  148. Klein E, Klein G: Immunological tolerance of neonatally infected mice to the Moloney leukemia virus. Nature 209:163, 1966

    Article  PubMed  CAS  Google Scholar 

  149. Kleist SV: Immune surveillance and tumor defense mechanisms. Path Res Pract 170:289, 1980

    Google Scholar 

  150. Korn D, Gelderman A, Cage G, Nathanson D, Strauss AJL: Immune deficiencies, aplastic anemia and abnormalities of lymphoid tissue in thymoma. N Engl J Med 276:1333, 1967

    Article  PubMed  CAS  Google Scholar 

  151. Kosmidis PA, Axelrod AR, Palacas C, Stahl M: Angioim-munoblastic lymphadenopathy: a T-cell deficiency. Cancer 42:447, 1978

    Article  PubMed  CAS  Google Scholar 

  152. Kraus M: Immunzytologische und immunfunktionelle Untersuchungen des lymphatischen Systems der C57B1-Maus bei kontinuierlicher oraler Applikation von N-Nitrosobutyl-Harnstoff in leukämogener und nicht-leukämogener Dosierung. Thesis, Cologne Univ Hundt Cologne (1981).

    Google Scholar 

  153. Kraus M, Krueger GRF: T- and B-cell determination in various lymphoid tissues of mice during N-ntirosobutylurea (NBU) leukemogenesis. J Cancer Res Clin Oncol 100:149, 1981

    Article  PubMed  CAS  Google Scholar 

  154. Kripke ML, Borsos T: Immunosuppression and carcinogenesis. Isr J Med Sci 10:888, 1974

    CAS  Google Scholar 

  155. Krueger G: Versuch einer immunologischen Deutung der Lymphomentstehung. Dtsch Med J 21:28, 1970a

    Google Scholar 

  156. Krueger GRF: Zur Pathogenese von Tumoren des lym-phoreticulären Gewebes bei Transplantatempfängern. Verh dtsch Ges Path 54:175, 1970b

    Google Scholar 

  157. Krueger GRF: Effect of dilantin in mice. I. Changes in the lymphoreticular tissue after acute exposure. Virchows Archiv A Path Anat 349:297, 1970c

    Article  CAS  Google Scholar 

  158. Krueger GRF: Impaired immunologic reactivity as pacemaker for lymphoma development. Verh dtsch Ges Path 55:200, 1971

    Google Scholar 

  159. Krueger GRF: Chronic immunosuppression and lym-phomagenesis in man and in mice. Natl Cancer Inst Monogr 35:183.90, 1972a

    PubMed  Google Scholar 

  160. Krueger GRF: Morphology of chemical immunosuppression. Adv Pharmacol Chemother 10:1, 1972b

    Article  PubMed  CAS  Google Scholar 

  161. Krueger GRF: Host response during the latent period and the growth of an immunologically induced mouse leukemia. Beitr Path 142:132, 1972c

    Google Scholar 

  162. Krueger GRF: Immunosuppression and experimental lymphoma. J Natl Cancer Inst 50:1412, 1973

    PubMed  CAS  Google Scholar 

  163. Krueger GRF: Lymphoreticular neoplasia in immunosuppression. Facts and fantasies. Beitr Path 151:221, 1974

    Google Scholar 

  164. Krueger GRF: The significance of immunosuppression and antigenic stimulation in the development of malignant lymphomas. Recent Results. Cancer Res 52:88, 1975

    PubMed  Google Scholar 

  165. Krueger GRF: Experimentelle Modelle immunologisch induzierter Tumoren. Verh dtsch Ges Inn Med 85:1460, 1979

    Google Scholar 

  166. Krueger GRF: Somatostatinoma of the liver. Leber Magen Darm 15(2):81, 1985b

    PubMed  Google Scholar 

  167. Krueger GRF, Bedoya VA: Hydantoin-induced lym-phadenopathies and lymphomas: Experimental studies in mice. Recent Results Cancer Res 64:265, 1978

    Google Scholar 

  168. Krueger GRF, Heine UI: Morphogenesis of two immunologically induced mouse lymphomas. Cancer Res 32:573, 1972

    PubMed  CAS  Google Scholar 

  169. Krueger GRF, Konorza G: Angioimmunoblastic lymphadenopathy in persistent virus infection? Lancet 11:1135, 1977

    Article  Google Scholar 

  170. Krueger GRF, Bedoya V, Grimley PM: Lymphoreticular tissue lesions in Steinbrinck-Chediak-Higashi syndrome. Virchows Archiv Abt A Path Anat 353:273, 1971b

    Article  Google Scholar 

  171. Krueger GRF, Fischer R, Flesch HG: Sequential changes in T- and B-cells, virus antigen expression, and primary histologic tumor diagnosis in virus-induced lymphomagenesis in mice. Z Krebsforsch 92:41, 1978

    CAS  Google Scholar 

  172. Krueger GRF, Harris D, Sussman E: Effect of dilantin in mice. II. Lymphoreticular tissue atypia and neoplasia after chronic exposure. Z Krebsforsch 78:290, 1972

    CAS  Google Scholar 

  173. Krueger GRF, Malmgren RA, Berard CW: Malignant lymphomas and plasmocytosis in mice under chronic immunosuppression and persistent antigenic stimulation. Transplant 11:138, 1971

    Article  CAS  Google Scholar 

  174. Krueger GRF, Karpinski A, Haas W, Lennert K: Angioimmunoblastic lymphadenopathy in persistent virus infection and hyperimmunization syndrome: Clinical and experimental data. XI Triennial World Congr Path Book of Abstracts, Jerusalem, 1981, p 160

    Google Scholar 

  175. Krueger GRF, Karpinski A, Heine UI, Koch B: Differentiation block of prethymic lymphocytes during Moloney virus-induced lymphoma development associated with thymic epithelial defect. J Cancer Res Clin Oncol, 106:102, 1983

    Article  PubMed  Google Scholar 

  176. Krueger GRF, Bergholz M, Bartsch H-H, Fischer R, Schauer A: Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL). J Cancer Res Clin Oncol 95:87, 1979

    Article  PubMed  CAS  Google Scholar 

  177. Lai PK, Mackay-Scollay M, Fimmel PJ, Alpers MP, Keast D: Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis. Nature 252:608, 1974

    Article  PubMed  CAS  Google Scholar 

  178. Lakshmi PN, Kolbe NP, Johri GN: Ancylostoma caninum: Transfer of lymphoid cells from thymus and adoptive immunity in mice. Int J Parasitol 12:227, 1982

    Article  PubMed  CAS  Google Scholar 

  179. Latner AL, Sherbet GV: Aprotinin induces surface changes in malignant cells in culture: A possible mode of antitumor action. Exp Cell Biol 47:392, 1979

    PubMed  CAS  Google Scholar 

  180. Law IP, Hollinshead AC, Whang-Peng I, Dean JH, Oldham RK, Herberman RB, Rhode MC: Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities. Cancer 39:1229, 1977

    Article  PubMed  CAS  Google Scholar 

  181. Leventhal BG, Talal N: Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol 104:918, 1970

    PubMed  CAS  Google Scholar 

  182. Lombeck I, Schnippering HG, Kasperek K, Ritzl F, Kästner H, Feinendegen LE, Bremer HJ: Akrodermatitis enteropathica — eine Zinkstoffwechselstörung mit Zinkmalabsorption. Z Kinderheilk 120:181, 1975

    Article  PubMed  CAS  Google Scholar 

  183. Look AT, Naegele RF, Callihan T, Herrod HG, Henle W: Fatal Epstein-Barr virus infection in the child with acute lymphoblastic leukemia in remission. Cancer Res 41:4280, 1981

    PubMed  CAS  Google Scholar 

  184. Louie S, Schwartz RS: Immunodeficiency and the pathogenesis of lymphoma and leukemia. Seminars Hematol 15:117, 1978

    CAS  Google Scholar 

  185. Low TLK, Thurman GB, Chincarini C, McClure JE, Marshall GD, Hu SK, Goldstein AL: Current status of thymosin research: Evidence for the existence of a family of thymic factors that control T-cell maturation. Ann NY Acad Sci 332:33, 1979

    Article  PubMed  CAS  Google Scholar 

  186. Malmgren RA, Bennison BE, McKinley TW: Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents. Proc Soc Exp Biol Med 79:484, 1952

    PubMed  CAS  Google Scholar 

  187. Marshall GD, Low TLK, Thurman GB, Hu SK, Rossio JL, Trivers G, Goldstein AL: Overview of thymosin activity. Cancer Treatm Rep 62:1731, 1978

    CAS  Google Scholar 

  188. Melief CJM, Schwartz RS: Immunocompetence and malignancy. In: Cancer, Vol I, edited by Becker FF, Plenum Press, NY, 1975, p 121–59

    Google Scholar 

  189. Melnick JF, Adam E, Rawls WE: The causative role of herpes virus type 2 in cervical cancer. Cancer 34:1375, 1974

    Article  PubMed  Google Scholar 

  190. Mertens H, Krueger GRF: Percent distribution of T- and B-lymphoid cells in spleen and lymph nodes of Moloney virus infected mice. Z Krebsforsch 85:169, 1976

    Article  CAS  Google Scholar 

  191. Metcalf D: The nature of leukemia: Neoplasm or disorder of hemopoietic regulation? Med J Aust 2:739, 1971

    PubMed  CAS  Google Scholar 

  192. Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, Singman H, Adelsberg RB, Spigland I: Opportunistic infection and immune deficiency in homosexual men. Ann Int Med 96:700, 1982

    PubMed  CAS  Google Scholar 

  193. Miller AM, Walma EP, Klapwijk, Van Bekkum DW: The effect of cyclosporin-A on host-versus-graft disease in canine bone marrow transplantation. Exp Hematol 10(Suppl 11):36, 1982

    Google Scholar 

  194. Miller DR: Familial reticuloendotheliosis: concurrence of disease in five siblings. Pediatrics 38:986, 1966

    PubMed  CAS  Google Scholar 

  195. Mills KH, Cawley JC: Suppressor T-cells in B-cell chronic lymphocytic leukaemia: Relationship to clinical stage. Leukemia Res 6:653, 1982

    Article  CAS  Google Scholar 

  196. Mills KH, Cawley JC: Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Brit J Haematol 53:271, 1983

    Article  CAS  Google Scholar 

  197. Moretta L, Mingari MC, Webb MC, Pearl ER, Lydyard PM, Crossi CE, Lawton AR, Cooper MD: Imbalances in T-cell subpopulations associated with immunodeficiency and autoimmune syndromes. Eur J Immunol 7:696, 1977

    Article  PubMed  CAS  Google Scholar 

  198. Moriya N, Miyawaki T, Ueno Y, Koizumi S, Taniguchi N: Humoral helper activity of B-cell differentiation released from non-Hodgkin’s lymphoma cells having both SRBC and complement receptors in the pokeweed mitogen system. Blood 57:1057, 1981

    Google Scholar 

  199. Moss DJ, Scott W, Pope JH: An immunologic basis for inhibition of transformation of human lymphocytes by EB virus. Nature 268:735, 1977

    Article  PubMed  CAS  Google Scholar 

  200. Muller CP: Wirkung der Zelldichte auf die Membranfluidität und deren Einfluß auf die Modulation spezifischer Membranrezeptoren. Thesis at Univ Cologne, Hansen, Cologne, 1979

    Google Scholar 

  201. Nakano K, Cinader B: Accelerated age-dependent decline in the T-suppressor capacity of SJL-mice. Eur J Immunol 10:309, 1980

    Article  PubMed  CAS  Google Scholar 

  202. Naor D: Unresponsiveness to modified self antigen — a censorship mechanism controlling autoimmunity? Immunol 50:187, 1980

    CAS  Google Scholar 

  203. Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H: Malignant lymphoma arising in angioimmunoblastic lym-phadenopathy. Cancer 41:578, 1978

    Article  PubMed  CAS  Google Scholar 

  204. Nelson K, Pollack S, Hellström KE: Specific anti-tumor response of cultured spleen cells. III. Further characterization of cells which synthesize factor with blocking and anti-serum-dependent cellular cytotoxic (ADC) activities. Int J Cancer 16:539, 1975

    Article  PubMed  CAS  Google Scholar 

  205. Nichols PW, Koss M, Levine AM, Lukes RJ: Lymphoma-toid Granulomatosis: A T-cell disorder? Amer J Med 72:467, 1982

    Article  PubMed  CAS  Google Scholar 

  206. Nicolson GL: Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta 458:1, 1976

    PubMed  CAS  Google Scholar 

  207. Notkins AL, Mergenhagen SE, Howard RJ: Effect of virus infections on the function of the immune system. Ann Rev Microbiol 24:525, 1970

    Article  CAS  Google Scholar 

  208. O’Conor GT: Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt’s tumor. Amer J Med 48:279, 1970

    Article  Google Scholar 

  209. Oppenheim JJ, Northoff H, Greenhill A, Mathieson BJ, Smith KA, Gills S: Properties of human monocyte-derived lymphocyte activating-factor (LAF) and lymphocyte-derived mitogenic factor (LMF). In: Biochemical Characterization of Lymphokines, edited by de Weck A, Academic Press NY, 1980, p 399

    Google Scholar 

  210. Orsini F, Eppolito C, Ehrke MJ, Mihich E: Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture. Cancer Treatm Rep 64:211, 1980

    CAS  Google Scholar 

  211. Outzen HC, Custer RP, Eaton GJ: Spontaneous and induced tumor incidence in germfree ‘nude’ mice. J Reticuloendothel Soc 17:1, 1975

    PubMed  CAS  Google Scholar 

  212. Page AR, Hansen AE, Good RA: Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood 21:197, 1963

    PubMed  CAS  Google Scholar 

  213. Pahwa RN, Pahwa SG, Good RA: T-lymphocyte differentiation in severe combined immunodeficiency: Defects of the thymus. Clin Immunol Immunopathol 11:437, 1978

    Article  PubMed  CAS  Google Scholar 

  214. Pandolfi F, Quinti I, Frieligsdorf A, Goldstein G, Businco L, Aiuti F: Abnormalities of regulatory T-cell subpopulations in patients with primary immunoglobulin deficiencies. Clin Immunol Immunopath 22:323, 1982

    Article  CAS  Google Scholar 

  215. Parker CW, Vavra JD: Immunosuppression. Progr Hematol 6:1, 1969

    CAS  Google Scholar 

  216. Pazmino NH, Ihle JN, Goldstein AL: Induction in vivo and in vitro of terminal deoxynucleotidyl transferase by thymosin in bone marrow cells from athymic mice. J Exp Med 147:708, 1978

    Article  PubMed  CAS  Google Scholar 

  217. Penn I: Occurrence of cancer in immune deficiencies. Cancer 34:858, 1974

    Article  PubMed  Google Scholar 

  218. Penn I: Tumors arising in organ transplant recipients. Adv Cancer Res 28:31, 1978

    Article  PubMed  CAS  Google Scholar 

  219. Penn I, Starzl TE: Malignant tumors arising de Novo in immunosuppressed organ transplant recipients. Transplant 14:407, 1972

    Article  CAS  Google Scholar 

  220. Peterson RD, Kelly WD, Good RA: Ataxia telangiectasia. Its association with a defective thymus, immunological deficiency disease and malignancy. Lancet 1:1189, 1964

    Article  PubMed  CAS  Google Scholar 

  221. Pizon I: Risques et dangers des radiations: radiations electro-magnetiques et corpuscules de haute energie. Presse Med 63:1158, 1955

    PubMed  CAS  Google Scholar 

  222. Pledger WJ, Howe PH, Leof GB: The regulation of cell proliferation by serum growth factors. Ann NY Acad Sci 397:1, 1982

    Article  PubMed  CAS  Google Scholar 

  223. Plescia OJ, Grinwich K, Plescia AM: Subversive activity of syngeneic tumor cells as an escape mechanism from immune surveillance and the role of prostaglandins. Ann NY Acad Sci 276:455, 1976

    Article  PubMed  CAS  Google Scholar 

  224. Prehn RT: Function of depressed immunologic reactivity during carcinogenesis. J Natl Cancer Inst 31:791, 1963

    PubMed  CAS  Google Scholar 

  225. Prehn RT: The immune reaction as a stimulation of tumor growth. Science 176:170, 1972

    Article  PubMed  CAS  Google Scholar 

  226. Prehn RT: Immunostimulation of highly immunogenic target tumor cells by lymphoid cells in vitro. J Natl Cancer Inst 56:833, 1976

    PubMed  CAS  Google Scholar 

  227. Prehn RT: Immunostimulation of the lymphodependent phase of neoplastic growth. J Natl Cancer Inst 59:1043, 1977

    PubMed  CAS  Google Scholar 

  228. Prehn RT, Lappé MA: An immunostimulation theory of tumor development. Transplant Rev 7:26, 1971

    PubMed  CAS  Google Scholar 

  229. Purtilo DT: Epstein-Barr virus-induced oncogenesis in immune-deficient individuals. Lancet I:300, 1980

    Article  Google Scholar 

  230. Purtilo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S: Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): Update on studies of the registry. Amer J Med 73:49, 1982

    Article  PubMed  CAS  Google Scholar 

  231. Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm A-C, Anvret M, Pritchard J, Rich K, Sloper C, Sieff C, Pincott J, Pachman L, Knight J, Sandtstedt B, Klein G: Documentation of Epstein-Barr virus infection in imm-unodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res 41:4226, 1981

    PubMed  CAS  Google Scholar 

  232. Rapp F, Reed CL: The viral etiology of cancer — a realistic approach. Cancer 40:419, 1977

    Article  PubMed  CAS  Google Scholar 

  233. Reinherz EL, Rosen FS: New concepts of immunodeficiency. Amer J Med 71:511, 1981

    Article  PubMed  CAS  Google Scholar 

  234. Reinherz EL, Schlossman SF: The differentiation and function of human T-lymphocytes. Cell 19:821, 1980

    Article  PubMed  CAS  Google Scholar 

  235. Reinherz EL: Cooper MD, Schlossman SF: Abnormalities of T-cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest 68:699, 1981a

    Article  PubMed  CAS  Google Scholar 

  236. Reinherz EL, Kung PC, Goldstein G, Schlossman SF: Further characterization of the human inducer T-cell subset defined by monoclonal antibody. J Immunol 123:2894, 1979a

    PubMed  CAS  Google Scholar 

  237. Reinherz EL, Parkman R, Rappaport J, Rosen FS, Schlossman SF: Abberations of suppressor T-cells in human graft-versus-host disease. N Engl J Med 300:1061, 1979b

    Article  PubMed  CAS  Google Scholar 

  238. Reinherz EL, Geha R, Wohl ME, Morimoto C, Rosen FS, Schlossman SF: Immunodeficiency associated with loss of T4+ inducer T-cell function. N Engl J Med 304:811, 1981b

    Article  PubMed  CAS  Google Scholar 

  239. Reinherz EL, Rubinstein A, Geha RS, Strelkauskas AJ, Rosen FS, Schlossman SF: Abnormalities of immu-noregulatory T-cells in disorders of immune function. N Engl J Med 301:1018, 1979c

    Article  PubMed  CAS  Google Scholar 

  240. Robins RA, Rees RC, Brooks CG, Baldwin RW: Spontaneous development of cytotoxic activity in cultured lymph node cells from tumour-bearing rats. Brit J Cancer 39:659, 1979

    Article  PubMed  CAS  Google Scholar 

  241. Rocklin RE, Bendtzen K, Greineder D: Mediators of immunity: lymphokines and monokines. Adv Immunol 29:55, 1980

    Article  PubMed  CAS  Google Scholar 

  242. Rosenthal CJ, Noguera CA, Coppola A, Kapeiner SN: Pseudolymphoma with mycosis fungoides manifestations hyperresponsiveness to diphenylhydantoin and lymphocyte dysregulation. Cancer 49:2305, 1982

    Article  PubMed  CAS  Google Scholar 

  243. Rosenstreich DL, Mitzel SB: The participation of macrophages cell lines in the activation of T-lymphocytes by mitogens. Immunol Rev 40:102, 1978

    Article  PubMed  CAS  Google Scholar 

  244. Rowland GF, Hurd CM: Target lymphoid cell population of carcinogen induced immunodepression in mice. Nature 227:167, 1970

    Article  PubMed  CAS  Google Scholar 

  245. Rubin BA: Alteration of the homograft response as a determinant of carcinogenicity. Progr Exp Tumor Res 14:138, 1971

    PubMed  CAS  Google Scholar 

  246. Russell SW, Gillespie GY, Pace JL: Comparison of responses to activating agents by mouse peritoneal macrophages and cells of the macrophage line RAW 264. J Reticuloendothel Soc 27:607, 1980

    PubMed  CAS  Google Scholar 

  247. Sakamoto K, Seeley J, Lindsten T, Sexten J, Yetz J, Bellow M, Purtilo DT: Abnormal anti-Epstein-Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J Immunol 128:904, 1982

    PubMed  CAS  Google Scholar 

  248. Saltzstein SL, Ackerman LV: Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer 12:164, 1959

    Article  PubMed  CAS  Google Scholar 

  249. Saxon A, Stevens RH, Golde DW: Helper and suppressor T-lymphocyte leukemia in ataxia teleangiectasia. N Engl J Med 300:700, 1979

    Article  PubMed  CAS  Google Scholar 

  250. Scheid MP, Hoffman MK, Komuro K, Hammerling H, Boyse EA, Cohen GH, Hooper JA, Schulof RS, Goldstein G: Differentiation of T-cells induced by preparations from thymus and by non-thymic agents. J Exp Med 138:1027, 1973

    Article  PubMed  CAS  Google Scholar 

  251. Schirrmacher V, Bosslet K, Shantz G, Clauer K, Hübsch D: Tumor metastases and cell mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T-lymphocytes. Int J Cancer 23:245, 1979

    Article  PubMed  CAS  Google Scholar 

  252. Schlesinger DH, Goldstein G, Scheid MP, Boyse EA: Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T-cell differentiation. Cell 5:367, 1975

    Article  PubMed  CAS  Google Scholar 

  253. Schwartz RS: Immunoregulation, oncogenic viruses and malignant lymphomas. Lancet I:1266, 1972

    Article  Google Scholar 

  254. Schwartz RS, Andre-Schwartz J: Malignant lymphoproliferative diseases: Interaction between immunological abnormalities and oncogenic viruses. Ann Rev Med 19:269, 1968

    Article  PubMed  CAS  Google Scholar 

  255. Schwartz RS, Beldotti L: Malignant lymphomas following allogenic disease: Transition from an immunological to a neoplastic disorder. Science 149:1511, 1965

    Article  PubMed  CAS  Google Scholar 

  256. Seeley JK, Sakamoto K, Ip S, Hansen P, Purtilo DT: Abnormal lymphocyte subsets of X-linked lymphoproliferative syndrome. J Immunol 127:2618, 1981

    PubMed  CAS  Google Scholar 

  257. Sciler FR, Schwick HG, eds: Interleukin 2 (International Workshop). Behring Inst Mitt 67:1, 1980

    Google Scholar 

  258. Shearer WT, Parker CW: Humoral immunostimulation. V. Selection of variant cell lines. J Exp Med 142:1133, 1975

    Article  PubMed  CAS  Google Scholar 

  259. Sherbet GV, ed: The biology of tumor malignancy. Academic Press, NY, 1982

    Google Scholar 

  260. Shinitzky M: Membrane changes in malignant cells — modulation of receptors and antigens by lipids. Bull Schweiz Acad Med Wiss 32:203, 1976

    CAS  Google Scholar 

  261. Shohat B, Spitzer S, Topilsky M, Trainin N: Immunological profile in sarcoidosis patients. The in vitro and in vivo effect of thymic humoral factors. Biomedicine Exp 29:91, 1978

    CAS  Google Scholar 

  262. Siegal FP, Siegal M, Good RA: Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemia patients. J Clin Invest 58:109, 1976

    Article  PubMed  CAS  Google Scholar 

  263. Siegal FP, Siegal M, Good RA: Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med 299:172, 1978

    Article  PubMed  CAS  Google Scholar 

  264. Sjögren HO: Blocking and unblocking of cell-mediated tumor immunity. Meth Cancer Res 10:19, 1973

    Google Scholar 

  265. Sjögren HO, Bansal SC: Antigens in virally induced tumors. Progr Immunol 1:921, 1971

    Google Scholar 

  266. Sjögren HO, Hellström I, Bansal SC, Hellström KE: Suggestive evidence that the blocking antibodies of tumor-bearing individuals may be antigen-antibody complexes. Proc Natl Acad Sci USA 63:1372, 1971

    Article  Google Scholar 

  267. Sonnabend JA, Witkin S, Purtilo DT: Etiologic factors and pathogenesis of acquired immunodeficiency syndrome (AIDS), opportunistic infections and malignancies in male homosexuals. J Amer Med Assoc 249:2370, 1983

    Article  CAS  Google Scholar 

  268. Spreafico F, Anaclerio A: Immunosuppressive agents. In: Comprehensive immunology, Vol 3 Immunopharmacology, edited by Hadden JW et al, Plenum, NY, 1977, p 245–278

    Google Scholar 

  269. Stjernswärd J: Immunodepressive effect of 3-methyl-cholanthrene. Antibody formation at the cellular level and reaction against weak antigenic homografts. J Natl Cancer Inst 35:885, 1965

    PubMed  Google Scholar 

  270. Stjernswärd J: Effect of noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro. J Natl Cancer Inst 36:1189, 1966

    PubMed  Google Scholar 

  271. Stjernswärd J: Further immunological studies of chemical carcinogenesis. J. Natl Cancer Inst 38:515, 1967

    PubMed  Google Scholar 

  272. Stjernswärd J: Immunosuppression by carcinogens. Antibiot Chemother 15:213, 1969

    PubMed  Google Scholar 

  273. Stutman O: Carcinogen-induced immune depression: Absence in mice resistant to chemical oncogenesis. Science 166:620, 1969

    Article  PubMed  CAS  Google Scholar 

  274. Stutman O: Immunodepression and malignancy. Proc XI Internatl Cancer Congr 1:275, 1974

    Google Scholar 

  275. Suciu-Foca N, Dumitrescu V, Lazar C, Nachtigal M: Host and tumor modifications associated with serial heterotransplantation of tumors through immunologically tolerant animals. Cancer Res 30:1681, 1970

    PubMed  CAS  Google Scholar 

  276. Sundar SK, Ablashi DV, Karamaju LS, Levine PH, Faggioni A, Armstrong GR, Pearson GR, Krueger GRF, Hewetson JF, Bertram G, Sesterhenn K, Menezes J: Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response. Int J Cancer 29:407, 1982

    Article  PubMed  CAS  Google Scholar 

  277. Szakal AK, Hanna MG: Immune suppression and carcinogenesis in hamsters during topical application of 7,12 dimethylbenz-α-anthracene. Natl Cancer Inst Monogr 35:173, 1972

    PubMed  CAS  Google Scholar 

  278. Tada T, Taniguchi David CS: Properties of the antigen specific suppressive T-cell factor in the regulation of antibody response in the mouse. IV. Special subregion assignment of the gene(s) that code(s) for the suppressive T cell factor in the H-2 histocompatibility complex. J Exp Med 144:713, 1976a

    Article  PubMed  CAS  Google Scholar 

  279. Tada T, Taniguchi M, Takemori T: Properties of primed suppressor T cells and their products. Transplant Rev 26:106, 1976b

    Google Scholar 

  280. Tamerius J, Hellström I, Hellström KE: Evidence that blocking factors in the sera of multiparous mice are associated with immunoglobulins. int J Cancer 16:456, 1975

    Article  PubMed  CAS  Google Scholar 

  281. Tamerius J, Nepom J, Hellström I, Hellström KE: Tumor-associated blocking factors: Isolation from sera of tumor-bearing mice. J Immunol 116:724, 1976

    PubMed  CAS  Google Scholar 

  282. Ten Bensel RW, Stadlan GM, Krivit W: The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68:761, 1966

    Article  PubMed  Google Scholar 

  283. Thomas JA, Janossy G, Graham-Braun JAC, Kung PC, Goldstein G: The relationship between T lymphocyte subsets and la-like antigen positive nonlymphoid cells in early stages of cutaneous T cell lymphoma. J Invest Dermatol 78:169, 1982

    Article  PubMed  CAS  Google Scholar 

  284. Ting CC, Rogers MJ: Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukemia-associated antigens. Nature 266:727, 1977

    Article  PubMed  CAS  Google Scholar 

  285. Trainin N, Kook AI, Umiel T: The nature of mechanism of stimulation of immune responsiveness by thymus extracts. Ann NY Acad Sci 249:349, 1975

    Article  PubMed  CAS  Google Scholar 

  286. Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR: Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor. Eur J Immunol 4:722, 1974

    Article  PubMed  CAS  Google Scholar 

  287. Trowell OA: Ultrastructural changes in lymphocytes exposed to noxious agents in vitro. Quart J Exp Physiol 51:207, 1966

    PubMed  CAS  Google Scholar 

  288. Turk JL, Parker D, Poulter LW: Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunol 23:493, 1972

    CAS  Google Scholar 

  289. Uchiyama T, Yodoi J, Sagawa K: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481, 1977

    PubMed  CAS  Google Scholar 

  290. Umiel T, Trainin N: Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes. Transplant 18:244, 1974

    Article  CAS  Google Scholar 

  291. Wainwright WH, Veltri RW, Sprinkle PM: Abrogation of cell-mediated immunity by a serum blocking factor isolated from patients with infectious mononucleosis. J Infect Dis 140:22, 1979

    Article  PubMed  CAS  Google Scholar 

  292. Walder BK, Robertson MR, Jeremy D: Skin cancer and immunosuppression. Lancet II:1282, 1971

    Article  Google Scholar 

  293. Waldmann TA, Durm M, Broder S, Blaese RM: Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinemia. Lancet II:609, 1974

    Article  Google Scholar 

  294. Waldmann TA, Broder S, Durm M: Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma. Trans Assoc Amer Physicians 88:120, 1975

    CAS  Google Scholar 

  295. Waldmann TA, Strober W, Blaese M: T- and B-cell immunodeficiency diseases. In: Clinical Immunol, Vol I, edited by Parker CW, Saunders, Philadelphia, 1980, p 314–375

    Google Scholar 

  296. Waldmann T-A, Blaese RM, Broder S, Krakauer RS: Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity. Ann Int Med 88:226, 1978

    PubMed  CAS  Google Scholar 

  297. Waldmann TA, Strober W, Blaese RM, Strauss AJM: Thymoma, hypogammaglobulinemia and absence of eosinophils. J Clin Invest 46:1127, 1967

    Article  Google Scholar 

  298. Wara DW, Ammann AJ: Activation of T-cell rosettes in immunodeficient patient by thymosin. Ann NY Acad Sci 249:308, 1975

    Article  PubMed  CAS  Google Scholar 

  299. Wara DW, Goldstein AL, Doyle NE, Ammann AJ: Thymosin activity in patients with cellular immunodeficiency. N Engl J Med 292:70, 1975

    Article  PubMed  CAS  Google Scholar 

  300. Warnatz H: Cell mediated immune reactions in patients with colon carcinoma. In: Immunodiagnosis and immunotherapy of malignant tumors, edited by Flad HD et al, Springer Verlag, Berlin, 1979, p 122–28

    Google Scholar 

  301. Wedderburn N, Salaman MH: The immunodepressive effect of friend virus. II. Reduction of splenic haemolysin-produc-ing cells in primary and secondary responses. Immunology 15:439, 1968

    PubMed  CAS  Google Scholar 

  302. Weiden PL, Robinett B, Graham TC, Adamson JW, Storb R: Canine cyclic neutropenia. A stem cell target. J Clin Invest 53:950, 1974

    Article  PubMed  CAS  Google Scholar 

  303. West WH, Cannon GB, Kay D, Bonnard BD, Herberman RB: Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: Characterisation of effector cells. J Natl Cancer Inst 58:355, 1977

    Google Scholar 

  304. White JG: The Chediak-Higashi syndrome: A possible lysosomal disease. Blood 28:143, 1966

    PubMed  CAS  Google Scholar 

  305. Williams RM: Experimental models with possible implications for the role of HLA in malignancy. In: HLA and malignancy, Alan Riss, NY, 1977, pp 21–28

    Google Scholar 

  306. Yu DTY, Paulus HE, Peter JB: Human lymphocyte subpop-ulations: Effect of immunosuppressive therapies. In: Lymphocytes and their interactions, edited by Williams RC, Raven Press, NY, 1975, p 157–68

    Google Scholar 

  307. Zembala M, Mytar B, Popiela T, Asherson GL: Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: The role of suppressor cells, 1977

    Google Scholar 

  308. Zollinger HU: Radio-histologie und radio-histopathologie. In: Handb Allg Path, edited by Büchner F et al, Springer Verlag, Berlin, NY, 1960, pp 127–287

    Google Scholar 

  309. Zur Hausen H: Oncogenic herpes viruses. Biochem Biophys Acta 417:25, 1975

    PubMed  Google Scholar 

Download references

Authors
  1. Gerhard R. F. Krueger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pittsburgh Cancer Institute, Pittsburgh, Pa., USA

    Ronald B. Herberman

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Dordrecht

About this chapter

Cite this chapter

Krueger, G.R.F. (1989). Abnormal Variation of the Immune System as Related to Cancer. In: Herberman, R.B. (eds) Influence of the Host on Tumor Development. Cancer Growth and Progression, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2530-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2530-4_19

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7643-2

  • Online ISBN: 978-94-009-2530-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation